 Home > Active Ingredient News > Infection > JAHA: The impact of influenza vaccine on the mortality and cardiovascular outcomes of patients with cardiovascular diseases

JAHA: The impact of influenza vaccine on the mortality and cardiovascular outcomes of patients with cardiovascular diseases

 Last Update: 2021-03-21
 Source: Internet
 Author: User

Tags

water research journal

polyurethane 2 part

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Influenza can be medsci.

medsci.

Researchers searched PubMed, Embase, and Cochrane libraries to identify randomized controlled trials and observational studies published before January 2020 to assess the impact of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular diseases.

The study identified a total of 16 studies (n=237058), including 4 randomized controlled trials (n=1667) and 12 observational studies (n=235391).

diabetes

When the median follow-up time was 19.

Cardiovascular event Myocardial infarction

It can be seen that the data of randomized controlled trials and observational studies support the current recommendations of clinical guidelines, that is, patients with cardiovascular diseases should be vaccinated against influenza to reduce mortality and cardiovascular events.

That is, patients with cardiovascular diseases are vaccinated against influenza to reduce mortality and cardiovascular events.

Original source:

Siva H.

Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis In this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

2-Mercaptobenzimidazole

CAS No.: 583-39-1

pharmaceutical grade

$100/KG FOB

Factory price Acetic acid 99.8% CAS NO. 64-19-7

CAS No.: 64-19-7

Industrial Grade

$200-250/MT FOB

100% Safe customs clearance high quality Sulfamethazine/Sulphadimidine CAS 57-68-1 with Best Price Sulfamethazine/Sulphadimidine

CAS No.: 57-68-1

Pharmacy Grade

$4-5/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.